Clinical Trials Browser

Interventional × apixaban × Clear all

NCT06886516 2026-04-15

Apixaban in Thrombocytopenia

Phase EARLY_PHASE1 Recruiting

Classical hematology

Pulmonary Embolism, Thrombocytopenia, Thromboembolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT07493304 2026-03-25

ROXI-CAT-II

Phase 3 Not yet recruiting

Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT05171049 2026-02-23

ASTER

Phase 3 Terminated

Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT07005024 2026-02-05

DOAC

Phase 3 Recruiting

Classical hematology

Neoplasms, Venous Thromboembolism

NCT05683808 2026-01-30

VTE-POG

Phase 2 Recruiting

CNSClassical hematology

Astrocytoma, Glioblastoma, Glioma, Venous Thromboembolism

NCT06243510 2026-01-28

CARE

Phase NA Enrolling by invitation

Urinary Bladder Neoplasms

NCT07270263 2025-12-26

HEM-DOAC

Phase NA Recruiting

Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Pulmonary Embolism, Hematologic Neoplasms, Venous Thromboembolism

NCT07189897 2025-10-08

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

Phase 4 Recruiting

Classical hematologyHead & Neck

Head and Neck Neoplasms, Thrombosis, Venous Thromboembolism

NCT06474182 2025-09-25

ProApix

Phase NA Recruiting

Multiple Myeloma

NCT07160686 2025-09-08

THROMBO-STOP

Phase 3 Not yet recruiting

Thromboprophylaxis

NCT07132515 2025-08-20

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

Phase 4 Recruiting

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT02066454 2025-08-13

MYELAXAT

Phase 3 Completed

Classical hematologyPlasma cell

Neoplasms, Plasma Cell, Venous Thromboembolism

NCT03045406 2025-06-24

CARAVAGGIO

Phase 3 Completed

1,170 enrolled 11 charts

Classical hematology

Venous Thromboembolism

NCT06603870 2025-05-30

STREAM-Line

Phase 4 Recruiting

Classical hematology

Neoplasms, Venous Thromboembolism, Catheter-Related Infections, Upper Extremity Deep Vein Thrombosis

NCT03080883 2025-05-18

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Phase 3 Completed

370 enrolled 16 charts

Other hematologic neoplasm

Neoplasm Metastasis, Pulmonary Embolism, Hematologic Neoplasms, Venous Thrombosis, Intracranial Thrombosis

NCT03692065 2025-02-06

API-CAT

Phase 3 Completed

Neoplasms, Thrombosis

NCT04243122 2024-05-29

AIRPORT-MPN

Phase 2 Completed

Classical hematologyMyeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT02744092 2023-10-03

CANVAS

Phase NA Completed

811 enrolled 19 charts

Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT01999179 2022-05-18

Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis

Phase NA Completed

27 enrolled 8 charts

Neoplasms, Venous Thrombosis

NCT02369653 2022-03-08

A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase

Phase 3 Completed

512 enrolled 26 charts

LymphoidOther hematologic neoplasm

Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04191928 2021-12-23

PAP-UP

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms, Pulmonary Embolism

NCT04106700 2021-02-15

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Phase 2 Terminated

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT02585713 2020-08-04

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Phase 3 Completed

300 enrolled 11 charts

Classical hematology

Neoplasm Metastasis, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Intracranial Thrombosis, Venous Thromboembolism, Mesenteric Ischemia

NCT04462003 2020-07-08

DVT

Phase 3 Unknown

Neoplasms, Venous Thrombosis

NCT02366871 2020-03-31

Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy

Phase 2 Completed

400 enrolled 16 charts

Classical hematology

Venous Thromboembolism

NCT03139487 2020-01-06

PRIORITY

Phase 2 Unknown

GastrointestinalSarcoma

Biliary Tract Neoplasms, Duodenal Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma, Gastrointestinal Stromal Tumors

NCT02958969 2019-12-17

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Phase 4 Completed

50 enrolled 5 charts

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT02048865 2018-11-20

AVERT

Phase 2 Completed

Classical hematology

Neoplasms, Venous Thromboembolism

NCT02581176 2018-06-26

CAP

Phase 4 Completed

Neoplasms, Venous Thrombosis

NCT03083782 2017-10-11

ACT

Phase 1 Completed

Classical hematology

Venous Thromboembolism

NCT00320255 2016-08-16

A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer

Phase 2 Completed

130 enrolled 22 charts

Neoplasms, Pulmonary Embolism, Thrombosis